TBPH Stock Summary and Trading Ideas (Theravance Biopharma - | NASDAQ:TBPH)

Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives. The company leverages decades of expertise and has developed FDA-approved YUPELRI (revefenacin) inhalation solution for the maintenance treatment of patients with COPD. Its ampreloxetine Phase 3 clinical study (CYPRESS) for the treatment of symptomatic neurogenic orthostatic hypotension in patients with multiple system atrophy did not meet its primary endpoint. The company operates in a single segment, the development and commercialization of human therapeutics, and operates in the United States, which generates maximum revenue, and Europe.

Theravance Biopharma - trades on the NASDAQ stock market under the symbol TBPH.

As of July 1, 2026, TBPH stock price declined to $16.98 with 1,265,718 million shares trading.

TBPH has a beta of 0.99, meaning it tends to be less sensitive to market movements. TBPH has a correlation of 0.07 to the broad based SPY ETF.

TBPH has a market cap of $880.04 million. This is considered a Small Cap stock.

Last quarter Theravance Biopharma - reported $18 million in Revenue and -$.10 earnings per share. This beat revenue expectation by $151,000 and missed earnings estimates by -$.16.

In the last 3 years, TBPH traded as high as $21.03 and as low as $7.44.

The top ETF exchange traded funds that TBPH belongs to (by Net Assets): VTI, IWM, VXF, IBB, IWO.

TBPH has outperformed the market in the last year with a price return of +53.9% while the SPY ETF gained +21.9%. However, in the short term, TBPH had mixed performance relative to the market. It has underperformed in the last 3 months, returning +11.3% vs +18.3% return in SPY. But in the last 2 weeks, TBPH shares have fared better than the market returning +1.7% compared to SPY -0.4%.

TBPH support price is $16.70 and resistance is $17.30 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TBPH shares will trade within this expected range on the day.